Published on
August 12, 2015
- 00:50 GMT
Avella selected by AstraZeneca to distribute IRESSA(r)(gefitinib)
Phoenix, AZ - (NewMediaWire) - August 11, 2015 - Avella Specialty Pharmacy announced today that it has been selected by AstraZeneca to distribute IRESSA® (gefitinib) for a sub-set of patients with metastatic EGFRm positive non-small cell lung cancer (NSCLC …
Distribution channels:
World & Regional
